ArticleslgStudy

chemistry

Ralimetinib

Ralimetinib is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Ralimetinib rather than just read about it. In short: Ralimetinib (LY2228820) is a small molecule experimental cancer drug in development by Eli Lilly. Although originally thought to be a p38 mitogen-activated protein kinase (MAPK) inhibitor, it has since been reported that it acts instead as an epidermal growth factor receptor (EGFR) inhibitor.

Ralimetinib — main illustration
Ralimetinib — illustration

Key takeaways

  • Ralimetinib belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Ralimetinib to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Ralimetinib from memory before moving on to harder problems.

Reference excerpt

Ralimetinib (LY2228820) is a small molecule experimental cancer drug in development by Eli Lilly. Although originally thought to be a p38 mitogen-activated protein kinase (MAPK) inhibitor, it has since been reported that it acts instead as an epidermal growth factor receptor (EGFR) inhibitor. A phase II trial for treatment of ovarian cancer has completed.

References

Illustrations

Ralimetinib illustration

Worked examples

Example 1 — a first encounter with Ralimetinib

Start with the simplest possible case. Write down what Ralimetinib claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Ralimetinib before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Ralimetinib ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Ralimetinib

In research
Ralimetinib appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Ralimetinib in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Ralimetinib is common in secondary-school and first-year university syllabi. It links to neighbouring topics 4-Fluorophenyl compounds, Drugs developed by Eli Lilly and Company, Drugs not assigned an ATC code, so understanding it makes those chapters shorter.
In everyday life
Look for Ralimetinib outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Ralimetinib” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Ralimetinib in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Ralimetinib means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Ralimetinib out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Ralimetinib in simple terms?

Ralimetinib (LY2228820) is a small molecule experimental cancer drug in development by Eli Lilly. Although originally thought to be a p38 mitogen-activated protein kinase (MAPK) inhibitor, it has since been reported that it acts instead as an epidermal growth factor receptor (EGFR) inhibitor.

Why does Ralimetinib matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Ralimetinib?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Ralimetinib.

Tags

  • 4-Fluorophenyl compounds
  • Drugs developed by Eli Lilly and Company
  • Drugs not assigned an ATC code
  • Experimental cancer drugs
  • Imidazoles
  • Protein kinase inhibitors
  • Tert-butyl compounds

Keep exploring